NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / USFDA pulls up Sun Pharma for lapses in Gujarat plant 
    India

    USFDA pulls up Sun Pharma for lapses in Gujarat plant 

    USFDA pulls up Sun Pharma for lapses in Gujarat plant 
    Written by Manzoor-ul-Hassan
    Jan 14, 2023, 04:12 pm 3 min read
    USFDA pulls up Sun Pharma for lapses in Gujarat plant 
    The US Food and Drug Administration (USFDA) questioned India's top drug maker Sun Pharma for alleged failures in preventing drug product contamination at its Gujarat-based factory

    The US Food and Drug Administration (USFDA) questioned India's top drugmaker Sun Pharma for alleged failures in preventing drug product contamination at its Gujarat-based factory, PTI reported. The health regulator issued a warning letter citing flaws at the Halol factory, which manufactures finished pharmaceutical goods. Notably, the warning was issued following an inspection conducted last year between April 26 and May 9.

    Why does this story matter?

    • The USFDA placed Sun Pharma's Halol unit on 'import alert' last week.
    • It means that future shipments of items developed at the plant will be denied entry into the US market unless they meet Current Good Manufacturing Practice (CGMP) requirements.
    • The company's supply reportedly decreased, falling to around 2.37% in the US market compared to 3% of the combined business in 2021-2022.

    USFDA declared Sun Pharma drug products adulterated

    According to reports, the USFDA's warning letter highlighted Sun Pharma's failure to implement quality control and other manufacturing practices at its plant in Halol, Gujarat. The prominent lacuna pointed out by the regulator includes a lack of a microbiological contamination system. "Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," it said.

    Drug regulator accuses Sun Pharma of violating rules 

    The following are some of the gaps identified by the USFDA in the letter: Inadequately delineated zones of sufficient size. Control mechanisms required to avoid contamination or mix-ups in aseptic processing facilities are not implemented. ISO 5 cleanroom spaces utilized for aseptic compounding and filling were poorly designed. Failure to employ appropriate equipment in the production, processing, packaging, or storage of pharmaceutical items.

    Pharma company also accused of operating ineffective quality system

    In addition, the US's health regulator also cited the Mumbai-based company's inability to adequately analyze any inexplicable disparity or failure of a batch. USFDA also criticized the pharma company for a lack of efforts to fulfill any of its criteria. "Significant findings in this letter demonstrate that your firm does not operate an effective quality system by CGMP," it noted.

    Sun Pharma's shares decline after USFDA warning  

    As per reports, the company shares closed 3.57% lower at Rs 980.95 on Thursday on the Bombay Stock Exchange (BSE) post the USFDA import alert. Soon Sun Pharma clarified saying it "continues to cooperate with the USFDA" and assured that necessary steps would be taken to resolve issues highlighted by the regulator. It also claimed the USFDA was satisfied with the company's remedies.

    What is Sun Pharma?

    Sun Pharma (Sun Pharmaceutical Industries Ltd.) is one of the world's largest generic pharmaceutical firms, with global sales of over $5.1 billion, per its website. It said that the pharmaceutical company was supported by more than 40 manufacturing facilities that produce high-quality, low-cost medications. In addition, it is claimed to be a well-known brand among healthcare professionals and people in over 100 countries.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Gujarat
    Bombay Stock Exchange (BSE)
    United States of America
    Sun Pharma

    Latest

    Amritpal Singh seen in Delhi without turban, wearing mask, sunglasses Delhi
    Apple releases iOS 16.4, iPadOS 16.4 updates: Check what's new Apple
    AI-generated images and the blurring lines between real and fake Artificial Intelligence and Machine Learning
    Shakib Al Hasan eyes 450-wicket mark in T20s: Key stats Shakib Al Hasan

    Gujarat

    Umesh Pal kidnapping case: Gangster-turned-politician Atiq Ahmed sentenced to life Prayagraj
    Gujarat: Bilkis Bano gangrape convict shares stage with BJP leaders Bilkis Bano
    Opposition meet today over RaGa's conviction in Modi surname case Congress Party
    New COVID-19 variant, XBB.1.16 detected in 349 samples: Govt COVID-19

    Bombay Stock Exchange (BSE)

    Adani Group's meltdown: Lenders, stock exchanges put conglomerate on notice Adani Group
    Investor alert: BSE now has 12 crore registered investor accounts Stock Market
    LIC IPO debuts on Dalal Street at discounted price Initial Public Offering (IPO)
    Paytm debuts on NSE, BSE: Find all key details here Paytm

    United States of America

    5 countries outside India where people can speak Hindi Travel And Tourism
    US: Nashville school shooter identified as 28-year-old transgender alumnus Shooting Incident
    6 killed in Nashville school shooting, Biden calls it 'heartbreaking' Shooting Incident
    US says it's watching Rahul Gandhi's case after MP disqualification Rahul Gandhi

    Sun Pharma

    Sensex climbs to 59,245 points, Nifty settles at 17,665 Sensex
    Sensex closes just below 58,300 points, Nifty ends at 17,382 Sensex
    BSE rebounds 69 points; market opens higher ahead of RBI-policy Bharti Airtel
    Sensex begins FY19 on firm note, rises over 100 points Japan

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023